Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+25.62%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$12.8B
AUM Growth
+$2.93B
(+30%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
16.93%
Holding
2,114
New
539
Increased
465
Reduced
390
Closed
657
Top Buys
| 1 |
T-Mobile US
TMUS
|
+$151M |
| 2 |
Procter & Gamble
PG
|
+$121M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Teleflex
TFX
|
+$95M |
| 5 |
UBS Group
UBS
|
+$86.2M |
Top Sells
| 1 |
PayPal
PYPL
|
+$256M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
Amazon
AMZN
|
+$131M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$121M |
| 5 |
Linde
LIN
|
+$97.6M |
Sector Composition
| 1 | Healthcare | 23.73% |
| 2 | Consumer Discretionary | 17.69% |
| 3 | Technology | 13.71% |
| 4 | Financials | 13.39% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
TIM SA
TIMB
$10B
| $1.05M | 0.01% |
+81,264
| New | +$1.05M |
|
952
TAL Education Group
TAL
$6.54B
| $1.05M | 0.01% |
15,338
-164,591
| -91% | -$11.3M |
|
953
Xenon Pharmaceuticals
XENE
$2.86B
| $1.04M | 0.01% |
+82,912
| New | +$1.04M |
|
954
Manulife Financial
MFC
$54B
| $1.04M | 0.01% |
77,800
+64,200
| +472% | +$857K |
|
955
PLDT
PHI
$4.19B
| $1.04M | 0.01% |
42,464
-57,565
| -58% | -$1.41M |
|
956
CoreCard
CCRD
$208M
| $1.04M | 0.01% |
30,376
-4,969
| -14% | -$169K |
|
|
NXGN
957
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.03M | 0.01% |
93,870
-17,712
| -16% | -$195K |
|
958
Saratoga Investment
SAR
$391M
| $1.03M | 0.01% |
64,977
-9,093
| -12% | -$144K |
|
959
Marvell Technology
MRVL
$57.4B
| $1.01M | 0.01% |
28,829
+27,151
| +1,618% | +$952K |
|
960
Fulton Financial
FULT
$3.51B
| $1.01M | 0.01% |
+95,868
| New | +$1.01M |
|
|
BEAT
961
DELISTED
BioTelemetry, Inc.
BEAT
| $1.01M | 0.01% |
+22,339
| New | +$1.01M |
|
962
StoneCo
STNE
$4.85B
| $1.01M | 0.01% |
+25,951
| New | +$1.01M |
|
|
CTEV
963
Claritev Corporation
CTEV
$1.04B
| $1M | 0.01% |
+2,318
| New | +$1M |
|
964
Robert Half
RHI
$3.56B
| $991K | 0.01% |
18,767
+18,457
| +5,954% | +$975K |
|
|
CIIC
965
DELISTED
CIIG Merger Corp. - Class A Common Stock
CIIC
| $990K | 0.01% |
100,000
| – | – |
|
|
OSB
966
DELISTED
Norbord Inc.
OSB
| $985K | 0.01% |
+43,285
| New | +$985K |
|
967
Raymond James Financial
RJF
$34.1B
| $983K | 0.01% |
21,426
-115,394
| -84% | -$5.29M |
|
968
Expedia Group
EXPE
$26.7B
| $982K | 0.01% |
11,943
-40,634
| -77% | -$3.34M |
|
969
NETSCOUT
NTCT
$1.8B
| $981K | 0.01% |
+38,393
| New | +$981K |
|
970
Rayonier
RYN
$4.04B
| $981K | 0.01% |
+41,585
| New | +$981K |
|
971
Qfin Holdings, Inc. American Depositary Shares
QFIN
$3.73B
| $978K | 0.01% |
+91,248
| New | +$978K |
|
972
Tandem Diabetes Care
TNDM
$836M
| $978K | 0.01% |
+9,890
| New | +$978K |
|
|
GOGL
973
DELISTED
Golden Ocean Group
GOGL
| $976K | 0.01% |
252,746
+62,590
| +33% | +$242K |
|
974
Coca-Cola Consolidated
COKE
$10.5B
| $974K | 0.01% |
42,480
-89,860
| -68% | -$2.06M |
|
|
PRSP
975
DELISTED
Perspecta Inc. Common Stock
PRSP
| $973K | 0.01% |
+41,873
| New | +$973K |
|